Chlamydia is a common sexually transmitted infection caused by the bacterium Chlamydia trachomatis. It can affect the genital tract, rectum, and throat, sometimes without noticeable symptoms. Treatment typically involves prescription antibiotics selected according to individual circumstances. Understanding medication options, completing the prescribed course, informing sexual partners, and attending recommended follow up testing.
Chlamydia is a bacterial infection that can be treated with appropriate antibiotics. Because many people experience no symptoms, testing is important when exposure is suspected or screening is recommended. Untreated infection may cause complications, including pelvic inflammatory disease in women and inflammation of the reproductive tract in men. Medical evaluation helps determine the appropriate treatment and whether additional testing is necessary.
Healthcare professionals select antibiotics based on established treatment guidelines, pregnancy status, possible complications, allergies, and other individual factors. Doxycycline is generally the preferred treatment for uncomplicated chlamydia in nonpregnant adults, while alternative medications may be appropriate in certain circumstances.
Treatment should be prescribed by a qualified healthcare professional rather than selected through self medication.
Doxycycline: For nonpregnant adolescents and adults, the recommended regimen is typically 100 mg by mouth twice daily for seven days. It is generally preferred because of its effectiveness, including for rectal infections.
Azithromycin: A single 1 gram oral dose is an alternative in selected situations, particularly when completing a seven day regimen may be difficult. Doxycycline is generally more effective for rectal chlamydia.
Amoxicillin: This medication may be used as an alternative during pregnancy when recommended by a healthcare professional. The usual guideline regimen is 500 mg orally three times daily for seven days.
Pregnancy considerations: Pregnant individuals require appropriate antibiotic selection and follow up. A test of cure is generally recommended approximately four weeks after treatment during pregnancy.
The appropriate medication and dosage depend on the clinical situation. Patients should follow their prescription instructions and discuss side effects, allergies, and other medicines with their healthcare professional.
Completing antibiotic treatment is important, but managing sexual partners and preventing reinfection are also essential. A person can become infected again after successful treatment if an untreated partner transmits the bacteria. Follow up recommendations vary according to pregnancy status, symptoms, and the possibility of continued exposure.
Avoid sexual activity: Avoid vaginal, anal, and oral sex until the seven day treatment course is completed, or for seven days after single dose treatment, and until sexual partners have been treated. Follow specific medical advice if treatment differs.
Inform recent partners: Sexual partners from the 60 days before symptom onset or diagnosis should generally be evaluated, tested, and treated. If the last sexual contact was more than 60 days earlier, the most recent partner should still be evaluated.
Repeat testing: Retesting approximately three months after treatment is recommended because reinfection is common. This is different from a test of cure, which checks whether the original infection has cleared.
Additional STI screening: Healthcare professionals may recommend testing for gonorrhea, HIV, and syphilis, depending on individual risk factors and clinical guidance.
Prompt diagnosis and appropriate treatment can reduce the risk of complications and transmission. Individuals who develop persistent symptoms, experience possible reexposure, or have concerns about medication should seek medical advice. Antibiotics treat chlamydia, but they do not provide protection against future infection, making appropriate testing, partner treatment, and preventive practices important parts of sexual health care.